Evofem Biosciences, Inc.
Ticker: 1618835
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 0.90-81.8% | 4.95+2.5% | 4.83+468.2% | 0.85-81.1% | 4.50+8.2% | 4.16+15.6% | 3.60-29.5% | 5.11 |
| Total Income | 0.90-81.8% | 4.95+2.5% | 4.83+468.2% | 0.85-81.1% | 4.50+8.2% | 4.16+15.6% | 3.60-29.5% | 5.11 |
| EXPENSES | ||||||||
| Expenditure | 5.47+36.7% | 4.00-34.2% | 6.08+1069.2% | 0.52-92.5% | 6.94+25.0% | 5.55-14.0% | 6.45-25.5% | 8.66 |
| Tax | 0.00 | 0.00-100.0% | 0.01 | — | -0.01-200.0% | 0.01 | — | 0.01 |
| PROFIT | ||||||||
| PBT | -5.47-248.4% | -1.57+11.8% | -1.78-285.4% | 0.96+140.5% | -2.37-274.3% | 1.36+128.3% | -4.81-107.3% | 66.02 |
| Net Profit | -5.47-248.4% | -1.57+11.8% | -1.78-285.4% | 0.96+140.5% | -2.37-275.6% | 1.35+128.1% | -4.81-107.3% | 66.01 |
| KEY METRICS | ||||||||
| OPM % | -100.00%-119.20pp | 19.20%+45.13pp | -25.93%-64.63pp | 38.70%+92.97pp | -54.27%-20.88pp | -33.39%+45.54pp | -78.93%-9.45pp | -69.48% |
| NPM % | -100.00%-68.31pp | -31.68%+5.29pp | -36.97%-136.97pp | 100.00%+152.60pp | -52.60%-85.08pp | 32.48%+132.47pp | -100.00%-200.00pp | 100.00% |
| EPS | -0.04-300.0% | -0.01+50.0% | -0.02-300.0% | 0.01+150.0% | -0.02-200.0% | 0.02+112.5% | -0.16-101.0% | 15.34 |
Corporate Events
No corporate events found.